Want to see JP:4438 full AI Analyst Report?
4438 Stock Chart & Stats
¥279.00
¥1.00(0.29%)
At close: 4:00 PM EST
¥279.00
¥1.00(0.29%)
Day’s Range― - ―
52-Week Range¥231.00 - ¥558.00
Previous CloseN/A
Volume4.50K
Average Volume (3M)3.91K
Market Cap
¥2.15B
Enterprise Value¥2.15K
Total Cash (Recent Filing)¥516.23M
Total Debt (Recent Filing)¥539.39M
Price to Earnings (P/E)―
Beta1.22
Next Earnings
Nov 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-63.35
Shares Outstanding8,435,582
10 Day Avg. Volume3,070
30 Day Avg. Volume3,910
Financial Highlights & Ratios
PEG Ratio0.13
Price to Book (P/B)8.48
Price to Sales (P/S)3.63
P/FCF Ratio-6.95
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue ReboundThe sharp 2025 revenue recovery indicates renewed demand or improved commercial execution. If sustained, higher scale could help absorb fixed costs and improve operating leverage, although the rebound remains volatile and has not yet produced profitability.
Strong Gross MarginsA high gross margin provides a favorable foundation for long-term profitability because substantial revenue remains after direct costs. The key opportunity is converting this gross profit into operating earnings through better scale and cost discipline.
Sizable Asset BaseThe sizable asset base provides an established operating platform and resources to support the company’s healthcare information-services activities. Its value is limited by rising leverage and losses, but it may still support future growth if capital allocation improves.
Bears Say
Persistent Heavy LossesSustained operating and net losses show that strong gross margins have not translated into a viable earnings model. Continued losses can erode equity, restrict investment capacity, and require restructuring or additional funding to achieve durable profitability.
Negative Cash GenerationNegative operating and free cash flow across all shown years indicates the business cannot currently fund operations and investment internally. Ongoing cash burn increases reliance on financing and makes execution of the growth strategy more financially demanding.
Rising LeverageMaterially higher leverage, combined with compressed equity and continuing losses, raises financial risk. Debt obligations may reduce flexibility to invest in products and growth, while further funding could dilute shareholders or increase financing costs.
4438 FAQ
What was Welby Inc.’s price range in the past 12 months?
Welby Inc. lowest stock price was ¥231.00 and its highest was ¥558.00 in the past 12 months.
What is Welby Inc.’s market cap?
Welby Inc.’s market cap is ¥2.15B.
When is Welby Inc.’s upcoming earnings report date?
Welby Inc.’s upcoming earnings report date is Nov 12, 2026 which is in 75 days.
How were Welby Inc.’s earnings last quarter?
Welby Inc. released its earnings results on Aug 13, 2026. The company reported -¥8.29 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Welby Inc. overvalued?
According to Wall Street analysts Welby Inc.’s price is currently Overvalued.
Does Welby Inc. pay dividends?
Welby Inc. does not currently pay dividends.
What is Welby Inc.’s EPS estimate?
Welby Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Welby Inc. have?
Welby Inc. has 8,435,582 shares outstanding.
What happened to Welby Inc.’s price movement after its last earnings report?
Welby Inc. reported an EPS of -¥8.29 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.172%.
Which hedge fund is a major shareholder of Welby Inc.?
Currently, no hedge funds are holding shares in JP:4438
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Welby Inc.
Established in Tokyo, Japan, in 2011, Welby Inc. specializes in developing digital healthcare solutions aimed at enhancing patients' access to and engagement with medical services. The company's extensive portfolio addresses a wide array of health conditions, encompassing diabetes mellitus, lifestyle-related diseases, mental health disorders, autoimmune and neurological diseases, rare conditions, oncology, and pain management. Furthermore, Welby is active in medical data surveying and operates its signature platform, Welby My Carte.